Rank #1223HRMY

Harmony Biosciences Holdings, I

$34.39

-2.52% (Daily)

Market Cap

$1.98B

Revenue

$825.94M

Rank by MCap

#1223

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Jeffrey S. Aronin

Headquarters

Plymouth Meeting, PA

Employees

268

About Harmony Biosciences Holdings, I

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase ...